PT  - JOURNAL ARTICLE
AU  - Busse, Gregory
TI  - Safety of IM Aripiprazole in Acute Agitation Associated with Dementia
DP  - 2007 Aug 01
TA  - MD Conference Express
PG  - 16--17
VI  - 7
IP  - 2
4099  - http://mdc.sagepub.com/content/7/2/16.short
4100  - http://mdc.sagepub.com/content/7/2/16.full
AB  - Aripiprazole is an atypical antipsychotic approved for the treatment of schizophrenia. Agitation is a common symptom experienced by patients with dementia, and medications with a rapid onset of action and appropriate tolerability in the elderly are desirable in these situations. This article discusses a multicenter, double-blind, placebo-controlled pilot study to determine the tolerability of intramuscular aripiprazole in patients with acute agitation associated with dementia and to determine a maximum tolerated dose.